Replies to post #72 on Protalix BioTherapeutics Inc (PLX)

[prophet_of_profit]

All we know is that it is going to be a 30-patient trial.

We also know that follows a single-center OPEN label phase-ONE trial.

The company did not explain the end-point(s) of either trial and never disclosed anything from the p-1 trial.

There's way too much hush-hush here and I can't understand investors that trust such a non-transparent company.

It seems like a $1.5 billion scam with hard-to-find shares to short.